EP Patent

EP2308491A1 — Pirfenidone therapy and inducers of cytochrome P450

Assigned to Intermune Inc · Expires 2011-04-13 · 15y expired

What this patent protects

The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.

USPTO Abstract

The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.

Drugs covered by this patent

Patent Metadata

Patent number: EP2308491A1
Jurisdiction: EP
Classification: —
Expires: 2011-04-13
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.